← Encyclopedia Cognitive and Neurological

Adalank

🔹 What is Adalank?

Class: N-Acetyl Selank Amidate — a structurally modified variant of Selank, the tuftsin-analog anxiolytic/nootropic heptapeptide. Mechanism:

  • Shares Selank’s core mechanism: modulates the GABAergic system for anxiolytic effects, supports BDNF expression for cognitive resilience, and carries immunomodulatory activity tied to the tuftsin backbone.
  • The N-acetyl and amidate modifications are intended to improve resistance to enzymatic degradation, extending duration of action compared to standard Selank — the same logic behind NA Semax Amidate’s relationship to standard Semax.
  • Marketed and discussed in the research community as an enhanced, longer-acting version of Selank rather than a distinct pathway. See this site’s Selank page for the standard, unmodified version this compound is derived from.

Primary focus:

  • Anxiety reduction (social/generalized) with a non-sedating profile.
  • Mood stabilization and stress resilience.
  • Cognitive support (focus, learning) layered on top of its anxiolytic effect.
  • Longer-duration alternative for those seeking less frequent dosing than standard Selank requires.

🔹 Oral Dosage: Not practical; poor oral bioavailability consistent with the base Selank molecule. Intranasal delivery is standard.


🔹 Injectable / Nasal Dosage (most common) Range:

  • Intranasal dosing typically discussed in the 200–600 mcg per dose range, generally on the lower/less-frequent end relative to standard Selank given its extended duration.

Frequency:

  • Often dosed once or twice daily, less frequently than standard Selank’s typical 2–3x daily schedule.

Rationale: Intranasal delivery allows direct nose-to-brain uptake; the amidated, N-acetylated modification is intended to reduce how often redosing is needed to maintain anxiolytic effect.


🔹 Cycle Length Common cycle length: 2–4 weeks of daily use, consistent with typical Selank-family research protocols. Off-cycle: Periodic breaks commonly discussed, particularly if used situationally for stress rather than as continuous daily use.


Educational Integration Example (nasal)

  • Example protocol: 300 mcg intranasal once daily, used situationally or over a 3–4 week window, chosen over standard Selank specifically for reduced dosing frequency.
  • Sometimes discussed alongside NA Semax Amidate for a combined anxiolytic-plus-cognitive research approach, mirroring how standard Selank and Semax are often paired given their shared Pro-Gly-Pro motif.

🔹 Stacking Strategy (Educational / Complementary) Since Adalank shares Selank’s anxiolytic/nootropic mechanism, complementary stacks follow the same logic as standard Selank: 🔸 Cognitive Pairing:

  • Semax or NA Semax Amidate: Complementary BDNF/dopaminergic cognitive support alongside Selank-family anxiolytic effects.

🔸 General Nootropic Support:

  • Other stress-resilience or mood-focused peptides may be layered depending on the specific research goal.

Rationale: As an enhanced-duration Selank variant, its stacking logic mirrors standard Selank’s — the main practical difference is frequency of dosing, not what it pairs well with.

Studied in Humans? Limited (primarily Russian research on Selank-family compounds; minimal Western clinical trials specific to this modified variant)

FDA Approved? No

Allowed for 503a Compounding Pharmacy? No

Disclaimer: Do not rely on any dosing information provided, this is for educational and research only. Always double and triple check alternative references for education. Please consult with healthcare provider for your specific dosing and protocol if applicable.